The association between serious infection and disease outcome in patients with rheumatoid arthritis

被引:7
|
作者
Iguchi-Hashimoto, Mikiko [1 ]
Hashimoto, Motomu [2 ]
Fujii, Takao [2 ]
Hamaguchi, Masahide [3 ]
Furu, Moritoshi [2 ]
Ishikawa, Masahiro [2 ]
Ito, Hiromu [2 ,4 ]
Yamakawa, Noriyuki [1 ]
Terao, Chikashi [5 ]
Yamamoto, Keiichi [6 ]
Yamamoto, Wataru [1 ,7 ]
Ohmura, Koichiro [1 ]
Mimori, Tsuneyo [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan
[3] Kyoto Prefectural Univ Med, Grad Sch Med, Dept Endocrinol & Metab, Kyoto, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan
[5] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan
[6] Osaka Univ, Grad Sch Med, Dept Clin Epidemiol & Biostat, Osaka, Japan
[7] Kurashiki Sweet Hosp, Dept Hlth Informat Management, Kurashiki, Okayama, Japan
关键词
Biological disease modifying anti-rheumatic drugs; Comorbidities; Glucocorticoids; Rheumatoid arthritis; Serious infection; MODIFYING ANTIRHEUMATIC DRUGS; RISK-FACTORS; GLUCOCORTICOID THERAPY; OLDER PATIENTS; LUNG-DISEASE; REGISTRY; METHOTREXATE; PROGRESSION; HOSPITALIZATION; ANTAGONISTS;
D O I
10.1007/s10067-015-3143-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to study the association between the past history of serious infection (SI) that required hospitalization and the current disease status of rheumatoid arthritis (RA), including disease activity, physical disability, and radiological joint destruction. The history of hospitalized infection was retrospectively analyzed in a cohort of 370 RA patients. The patients were divided into three groups based on the number of SI events (SI = 0, SI = 1, SI >= 2). Disease activity score using 28 joints (DAS28), Health Assessment Questionnaire (HAQ), and modified total sharp score (mTSS) adjusted after disease duration or other confounding factors were compared among the three groups. Among the study patients, 7.3 % (27 patients) experienced single SI (SI=1) and 2.1 % (8 patients) experienced multiple SI events (SI >= 2). Compared with patients with no SI (SI=0), patients with SI (SI = 1 or SI >= 2) had increased pulmonary and autoimmune comorbidities and were more frequently treated with glucocorticoids. DAS28 was not different among the groups, while HAQ and mTSS increased with the number of SI. After adjustment, only mTSS adjusted after disease duration remained statistically significantly different between patients with SI=0 and SI >= 2 (p=0.030). Multiple SI events are associated with advanced physical disability and radiological joint destruction in patients with RA.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 50 条
  • [1] The association between serious infection and disease outcome in patients with rheumatoid arthritis
    Mikiko Iguchi-Hashimoto
    Motomu Hashimoto
    Takao Fujii
    Masahide Hamaguchi
    Moritoshi Furu
    Masahiro Ishikawa
    Hiromu Ito
    Noriyuki Yamakawa
    Chikashi Terao
    Keiichi Yamamoto
    Wataru Yamamoto
    Koichiro Ohmura
    Tsuneyo Mimori
    [J]. Clinical Rheumatology, 2016, 35 : 213 - 218
  • [2] THE ASSOCIATION BETWEEN REPEATEDLY INFECTION AND DISEASE OUTCOME IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Zhang, R.
    He, J.
    Li, C.
    Li, J.
    Chen, J.
    Jin, Y.
    Gan, Y.
    Li, Z.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1144 - 1144
  • [3] The association between lymphopenia and serious infection risk in rheumatoid arthritis
    Subesinghe, Sujith
    Kleymann, Alexander
    Rutherford, Andrew Ian
    Bechman, Katie
    Norton, Sam
    Galloway, James Benjamin
    [J]. RHEUMATOLOGY, 2020, 59 (04) : 762 - 766
  • [4] THE RISK FACTORS OF SERIOUS INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hasegawa, E.
    Kobayashi, D.
    Ito, S.
    Narita, I.
    Nakazono, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1061 - 1061
  • [5] Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease
    Jorge A. Zamora-Legoff
    Megan L. Krause
    Cynthia S. Crowson
    Jay H. Ryu
    Eric L. Matteson
    [J]. Clinical Rheumatology, 2016, 35 : 2585 - 2589
  • [6] Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease
    Zamora-Legoff, Jorge A.
    Krause, Megan L.
    Crowson, Cynthia S.
    Ryu, Jay H.
    Matteson, Eric L.
    [J]. CLINICAL RHEUMATOLOGY, 2016, 35 (10) : 2585 - 2589
  • [7] Serious infection with tofacitinib in patients with rheumatoid arthritis: the importance of context
    Rivas, Jose L.
    Jones, Thomas
    Connell, Carol A.
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (12): : E738 - E738
  • [8] Association Between the Number of Comorbidities and the Risk of a Serious Infection in Rheumatoid Arthritis Treated by a First Biologic Agent
    Banse, Christopher
    Houivet, Estelle
    Loison, Aurelien
    Varin, Remi
    Pouplin, Sophie
    Lequerre, Thierry
    Vittecoq, Olivier
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (01) : E270 - E273
  • [9] The association between disease duration and mood disorders in rheumatoid arthritis patients
    Geng, Yan
    Gao, Tianjing
    Zhang, Xiaohui
    Wang, Yu
    Zhang, Zhuoli
    [J]. CLINICAL RHEUMATOLOGY, 2022, 41 (03) : 661 - 668
  • [10] Risk for Serious Infection in Rheumatoid Arthritis Associated Interstitial Lung Disease
    Zamora-Legoff, Alex
    Krause, Megan
    Crowson, Cynthia S.
    Ryu, Jay H.
    Matteson, Eric L.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68